Eloxx Pharmaceuticals
(OTC) ELOX
Eloxx Pharmaceuticals Financials at a Glance
Market Cap
$429,100
Revenue (TTM)
$0.00
Net Income (TTM)
$20.48M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-16882.27 (Low)
Dividend
$0.00
Beta (Volatility)
-16882.27 (Low)
Price
$0.08
Volume
11,173
Open
$0.14
Price
$0.08
Volume
11,173
Open
$0.14
Previous Close
$0.13
Daily Range
$0.08 - $0.14
52-Week Range
$0.08 - $0.75
Dividend
$0.00
Beta (Volatility)
-16882.27 (Low)
Price
$0.08
Volume
11,173
Open
$0.14
Previous Close
$0.13
Daily Range
$0.08 - $0.14
52-Week Range
$0.08 - $0.75
ELOX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Eloxx Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
10
CEO
Sumit Aggarwal, MBA
Website
www.eloxxpharma.comHeadquarters
Watertown, MA 02472, US
ELOX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
54%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$429.10K
Shares Outstanding
3.30M
Volume
11.17K
Short Interest
0.00%
Avg. Volume
5.87K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$6.44M
EBITDA
$6.44M
Operating Cash Flow
$6.33M
Capital Expenditure
$0.00
Free Cash Flow
$6.33M
Cash & ST Invst.
$4.79M
Total Debt
$1.00M
Eloxx Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$429.10K
N/A
Market Cap/Employee
$23.84K
N/A
Employees
18
N/A
Net Income
$3.59M
+52.2%
EBITDA
$3.17M
+53.6%
Quarterly Fundamentals
Net Cash
$3.79M
-35.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$1.00M
-78.7%
Return on Assets
-1.14%
N/A
Return on Invested Capital
54.07%
N/A
Free Cash Flow
$3.45M
+50.7%
Operating Cash Flow
$3.45M
+50.3%